Vertex Pharmaceuticals
NEWS
It was a busy week for clinical trial updates. Here’s a look.
Based on the positive results of Trikafta, the company plans to submit sNDA to the FDA in the fourth quarter and other regulatory agencies around the world afterward.
Biopharma and life sciences companies bolster their leadership teams and board with these Movers & Shakers.
It was a fairly busy week with clinical trial updates and announcements. Here’s a look.
Although some clinical trials are being slowed or halted, others are reporting out data. Here’s a look.
The $500,000 gift was in response to the COVID-19 outbreak and a need for more support, testing capacity and advancements.
The U.S. Food and Drug Administration has two PDUFA dates this week, one for a type of epilepsy and the other for a triple-combination drug for cystic fibrosis. Here’s a look.
The most recent BioSpace Ideal Employer Report revealed the impact of team dynamics on employees within life sciences organizations.
The BioSpace Ideal Employer Report examined aspects regarding the importance of culture within life sciences organizations.
JOBS
IN THE PRESS